McDonald's Corp reported a bigger-than-expected rise in worldwide October sales at established restaurants as it continues to outperform competitors in an uncertain global economy.
More homeowners were 60 days late or more on mortgage payments in the period of June to September, the first increase since the end of 2009, according to credit reporting agency TransUnion.
Research In Motion will lose more market share in the United States and see its international growth limited as the rollout of the Blackberry maker's new operating platform hits snags, Barclays said, downgrading the stock by a notch to equalweight.
As Herman Cain announced a Tuesday afternoon press conference to deny a fourth woman's claim that he sexually harassed her, the woman, Sharon Bialek, said she stood by her story. Even some of Cain's supporters say he needs to go beyond blanket denials now that there is a name and a face attached to the allegations.
Toyota has withdrawn its profit and sales forecasts for the full fiscal year given the continuing uncertainties posed by the Thai flooding.
In a private conversation with U.S. President Barak Obama, French President Nicolas Sarkozy has termed Israeli Prime Minister Benjamin Netanyahu as a liar and said, I can't stand him (Netanyahu).
Metals clients of failed U.S. broker dealer MF Global's British unit face delays in their positions being transferred to new brokers after a problem with London Metal Exchange (LME) data slowed the migration process, industry sources said on Tuesday.
Mark Zuckerberg dropped out of Harvard in 2004 and went on to make the biggest, most dominant social network. He returned to his alma mater Monday and gave an inspiring talk to students.
The roadmap to President Barack Obama's re-election could lie in the response to a question buried in a recent Suffolk University Poll.
A study out Monday adds to evidence that a newer type of birth control pill may carry a higher risk of blood clots than older versions.
Sales of Airbus' revamped A320neo topped 1,000 as the European planemaker extended its lead over Boeing in the annual tug-of-war for jetliner sales, figures showed Tuesday.
Perhaps the most invidious, appalling action during the financial crisis was the decision by the U.S. Federal Reserve to take over New York-based American International Group (AIG) in Sept. 2008. And it was the most necessary.
International Business Times spoke to a Greek native for her personal view on the crisis.
Veteran film critic Roger Ebert said that his At the Movies television show will leave the airways at the end of the current season unless funding is found in the coming days to continue financing it.
A federal judge blocked a U.S. rule requiring tobacco companies to display graphic images on cigarette packs, such as a man exhaling cigarette smoke through a hole in his throat.
Stocks were set for a higher open on Tuesday as Italian lawmakers prepared for a crucial vote on public finances that marks the latest turn in the long-simmering euro zone debt crisis.
Stocks were set for a higher open on Tuesday as Italian lawmakers prepared for a crucial vote on public finances that marks the latest turn in the long-simmering euro zone debt crisis.
Herman Cain has been accused of sexual harassment for the fourth time Monday. This is the first time when a person came publicly and accused the Republican presidential candidate of wrongdoings.
McDonald's Corp reported a higher-than-expected rise in worldwide October sales at established restaurants, aided by a popular promotional game in the United States.
India gold futures extended gains despite steady overseas markets, as prices tracked a weaker rupee, but physical buying was subdued by the high costs, dealers said.
The top pre-market NASDAQ Stock Market gainers are: McCormick & Schmick's Seafood Restaurants, BioCryst Pharmaceuticals, Central European Distribution, DryShips, and Polycom. The top pre-market NASDAQ Stock Market losers are: Targacept, Amylin Pharmaceuticals, SemiLEDs, Allot Communications, and Legacy Reserves.
Drug maker Bristol-Myers Squibb Co. (NYSE:BMY) said it has won the approval of the U.S. Food and Drug Administration (FDA) for the expanded use of its cancer drug, Erbitux.
